Viorgon-19

Liver tissue bioregulator.

Composition: 1 ml of a sterile solution contains: 0.1 ± 0.01 mg of CaCl2 and 10⁻¹⁰-10⁻¹¹ mg of a protein-peptide complex isolated from large celandine (Chelidonium majus).

Physiological effect: Viorgon 19 is associated with its property to additionally activate cellular regeneration sources in the parenchymal tissue of the liver, exert a regulatory effect on glandular cells of organs.

Recommendations for use: Viorgon-19 is recommended for diseases of the liver and endocrine glands of the body, including fatty degeneration, fibrosis, cirrhosis.

Mode of application
Viorgon can be taken by application to the mucous membrane, intranasally: by instilling into the nasal cavity, or sublingually: by ordering under the tongue. In this case, the dosage starts from 3 drops.

Viorgon can be taken orally, diluting in water at the rate of at least 8-10 drops per 100 ml of water. Drink at least 20-30 minutes before eating or 2 hours after.

A positive effect is observed from the use of 3 or more times a day. An overdose of viorgon preparations is excluded, it is allowed to take as many times a day as they will favorably affect the well-being. The addictive effect is also absent.

The interval between the various viorgons is at least 10 minutes.